De Greef E, Turner D, Kierkus J, Korczowski B, et al. Ustekinumab therapy for moderately to severely active pediatric Crohn's disease: UNITI Jr study safety and efficacy results in patients weighing at least 40 kg. J Crohns Colitis 2026;20:jjag011.
PMID: 41843763